Literature DB >> 20537572

Characteristics of polycystic ovarian syndrome and relationship with ghrelin in adolescents.

I T Ozgen1, M Aydin, A Guven, Y Aliyazicıoglu.   

Abstract

OBJECTIVE: Some points of pathogenesis in polycystic ovarian syndrome (PCOS) are still unknown. In this study we evaluated the characteristics of this disease and its relationship with ghrelin in adolescence.
DESIGN: A prospective case control study was designed. Four groups: obese PCOS (n = 13), lean PCOS (n = 13), obese control (n = 10) and lean control (n = 10) were formed. Oral glucose tolerance tests (OGTT) were performed on all subjects. Laboratory and clinical features of groups were compared.
SETTING: University pediatric endocrinology clinic. PARTICIPANTS: Adolescents with PCOS.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Insulin resistance, ghrelin, delta ghrelin (difference of ghrelin between basal and 120(th) minute after OGTT), androgens
RESULTS: Insulin resistance ratios were 93.3%, 46.6%, 50% in obese PCOS, lean PCOS and obese controls respectively. Ghrelin levels were lower in obese PCOS group but statistically different only between obese and lean PCOS groups. Ghrelin was correlated negatively with HOMA-IR (P < 0.001), 17 OH progesterone (P = 0.05), total (P = 0.015) and free testosterone (P = 0.013). Ghrelin suppression was blunted in PCOS groups. Ghrelin suppression ratios after glucose load were 24.4%, 28.7%, 36%, 35% obese PCOS, lean PCOS, obese control and lean control groups respectively.
CONCLUSION: Low ghrelin levels in obese PCOS patients, correlations between insulin resistance, androgens and ghrelin, blunted suppression of ghrelin after glucose load in PCOS have been considered as evidences of ghrelin role in pathogenesis of this syndrome.
Copyright © 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537572     DOI: 10.1016/j.jpag.2010.02.011

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  8 in total

1.  Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.

Authors:  Margaret C Garin; Samantha F Butts; David B Sarwer; Kelly C Allison; Suneeta Senapati; Anuja Dokras
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

Review 2.  Gastrointestinal hormones and polycystic ovary syndrome.

Authors:  Jing Ma; Tzu Chun Lin; Wei Liu
Journal:  Endocrine       Date:  2014-05-04       Impact factor: 3.633

Review 3.  Multiomics Analysis-Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome.

Authors:  Shikha Rani; Piyush Chandna
Journal:  Reprod Sci       Date:  2022-01-27       Impact factor: 3.060

Review 4.  Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Tian Gao; Lang Wu; Fuhou Chang; Guifang Cao
Journal:  Endocr J       Date:  2015-11-26       Impact factor: 2.349

5.  Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS.

Authors:  Sarah E Hoover; Barbara A Gower; Yenni E Cedillo; Paula C Chandler-Laney; Sarah E Deemer; Amy M Goss
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

6.  Serum acylated ghrelin is negatively correlated with the insulin resistance in the CODING study.

Authors:  Peyvand Amini; Danny Wadden; Farrell Cahill; Edward Randell; Sudesh Vasdev; Xihua Chen; Wayne Gulliver; Weizhen Zhang; Hongwei Zhang; Yanqing Yi; Guang Sun
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

8.  Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids.

Authors:  Jiaxi Li; Pu Huang; Jing Xiong; Xinyue Liang; Mei Li; Hao Ke; Chunli Chen; Yang Han; Yanhong Huang; Yan Zhou; Ziqiang Luo; Dandan Feng; Chen Chen
Journal:  Endocr Connect       Date:  2022-05-27       Impact factor: 3.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.